Notice of updates

We’ve updated our Financial Services Guide (FSG), effective 18 November 2025. By continuing to use our services after this date, you accept the revised terms.

Read FSG

icon
HALO logo
halo search icon
Global X S&P Biotech ETF
Global X S&P Biotech ETF
CURE · ASX

Global X S&P Biotech ETF

AU$59.31

Price Arrow0.10 (0.169%)
13/11/2025 03:21:05 PM
All-ETFSGROWTH AUSNear 52 Week HighNear Resistance
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Global X S&P Biotech ETF Overview

CURE Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About CURE

icon

Telephone

icon

Address

Description

N/A

CURE Price Chart

Key Stats

Market Cap

AU$41.72M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 38.76 - 59.64

Trade Value (12mth)

AU$24,066.00

1 week

3.51%

1 month

7.09%

YTD

19.64%

1 year

13.21%

All time high

86.04

Key Fundamentals

EPS 3 yr Growth

N/A

EBITDA Margin

N/A

Operating Cashflow

N/A

Free Cash Flow Return

N/A

ROIC

N/A

Interest Coverage

0.00

Quick Ratio

N/A

Other Data

Shares Outstanding (Fully Diluted)

N/A

HALO Sector

Other Finance

Next Company Report Date

N/A

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

CURE Fundamentals

Per Share Records

Historical data

Forecast data

2020202120222023202520262027

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

0%

Quality Yield

lock

Falling Divs over next 2

lock

Values and Recommendations

Key Stats

Consensus Score

lock

Recommendation

lock

EPS 1 month Change

lock

Quality Yield

lock

Falling Divs over next 2

lock

Short Selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

0

7 Day Change

0.00%

1 Month Change

0.00%

3 Months Change

0.00%

Dividend
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

CURE Shortsell

Want to learn more?Frequently asked questions.
What is the current share price of Global X S&P Biotech ETF (CURE:ASX)?
Halo FAQ
The current share price of Global X S&P Biotech ETF (CURE:ASX) is AUD$59.31.
What is the 52-week high share price for Global X S&P Biotech ETF (CURE:ASX)?
Halo FAQ
The 52-week high share price for Global X S&P Biotech ETF (CURE:ASX) is AUD$59.64.
What is the 52-week low share price for Global X S&P Biotech ETF (CURE:ASX)?
Halo FAQ
The 52-week low share price for Global X S&P Biotech ETF (CURE:ASX) is AUD$38.76.
What is the dividend yield for Global X S&P Biotech ETF (CURE:ASX)?
Halo FAQ
Global X S&P Biotech ETF (CURE:ASX) does not pay a dividend.
What was Global X S&P Biotech ETF (CURE:ASX) last dividend payment?
Halo FAQ
The last dividend payment of Global X S&P Biotech ETF (CURE:ASX) is AUD$0.02.
What is the franking level for Global X S&P Biotech ETF (CURE:ASX)?
Halo FAQ
Global X S&P Biotech ETF (CURE:ASX) has a franking level of 0.00%.
In which sector is Global X S&P Biotech ETF (CURE:ASX) classified?
Halo FAQ
Global X S&P Biotech ETF (CURE:ASX) is classified in the Other Finance.

See beyond the curve.

One solution for research, investing and portfolio management.